No Data
No Data
Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $60
Piper Sandler Sticks to Their Buy Rating for Q32 Bio (QTTB)
Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Raises Target Price to $60
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)
Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)
Q32 Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results.
No Data